High performance liquid chromatographic determination of Picumast and two active metabolites in plasma using on-line sample preparation.

A method for determining Picumast, an antiallergic drug, in plasma by HPLC and column switching has been developed. The system consisted of two precolumns, an analytical column, three pumps, an autosampler and a fluorescence detector. The precolumns (17 x 4.6 mm i.d.) were packed with LiChroprep RPR (a moderately polar reversed phase) and the analytical column with Nucleosil ODS (RP 18, 5 microns). The columns were connected according to the alternating precolumn technique. The mobile phase consisted of 30% CH3CN/70% 0.05 M KH2PO4, pH 2.5, with a flow gradient. Detection wavelengths were 333 nm for excitation and 383 nm for emission. The retention times of Picumast, M1 and M2 were 12, 3.6 and 4.0 min, respectively. Total run time was 15 min. The limit of detection was 3 ng/mL for M1 and 1 ng/mL for M2 and Picumast using an injection volume of 150 microL. The recoveries vary between 89% and 97% with standard deviations between 2.4 and 3.3%.     

On the strong monotonicity of power indices

The problem of choosing a power index which better describes a control situation could be solved by the property of strong monotonicity. We prove this property for some of the best known power indices.sponsored by Committee 10 of C.N.R.     

Magnetopause plasma transients: mapping into the auroral ionosphere

Attention is focused on a specific category of auroral event occurring predominantly during a southward directed interplanetary magnetic field (IMF). Coordinated observations from the ground and satellites in polar orbit have been used to study the temporal/spatial development of the events in relation to the background patterns of particle precipitation and ionospheric convection as well as the field-aligned current and ion drift characteristics of the individual events. Both prenoon and postnoon sector events are reported. In one case the auroral event was observed near the zero point potential line separating the morning and postnoon convection cells. The available data indicate that this auroral event sequence is a signature of quasi-periodic bursts of particle entry from the magnetosheath along flux tubes convecting into the polar cap, representing structures of enhanced IMF B_Y-related convection poleward of the persistent cleft aurora. Such events may be initiated by localized patches of enhanced merging rate at the dayside magnetopause     

Rotational Spectra of Argon Acetone: A Two-Top Internally Rotating Complex

The rotational spectra of the argon acetone weakly bound complex was studied by pulsed jet Fabry-Perot Fourier transform microwave spectroscopy. Over 500 transitions of the complex were measured between 5.5 and 26 GHz from J=2-1 to J=12-11. The two methyl groups undergo hindered internal rotation resulting in four or five internal rotation states. The microwave transitions are within these states, resulting in a splitting of each rotational transition into four and sometimes five distinct transitions. The three-fold barrier to internal rotation is determined to be 260 cm⁻¹, 2% less than the 266 cm⁻¹ barrier in acetone itself. The structure of the complex has the argon atom above the heavy atom plane of the acetone, 3.52 Å from the CO bond and approximately in the C_s plane, which is perpendicular to the CCC plane of acetone.     

Luminescence of self-trapped excitons in calcium fluoride under pulsed electron irradiation

Time-resolved pulsed spectroscopy was used to measure the luminescence spectra of calcium fluoride. Characteristic features of the luminescence of self-trapped excitons are discussed. It is shown that various configurations of self-trapped excitons incorporating hole nuclei of a more complex structure, may be formed in CaF₂ crystals. Fiz. Tverd. Tela (St. Petersburg) 40, 1226–1227 (July 1998)     

Synthesis of metabolites of 3-O-t-butylmorphine

The synthesis of 2-hydroxymethyl-2-propylmorphine ( 5 ) and 2-hydroxymethyl-2-propylnormorphine ( 7 ), the major rat urinary metabolites of 3-O-t-butylmorphine ( 3 ) are described.